国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
5期
942-944
,共3页
青光眼%新生血管性%青光眼阀%睫状体光凝术
青光眼%新生血管性%青光眼閥%睫狀體光凝術
청광안%신생혈관성%청광안벌%첩상체광응술
glaucoma%neovascular%glaucoma valve%ciliary body photocoagulation
目的：对比观察两种手术方法治疗新生血管性青光眼( NVG)的疗效。<br> 方法：对46例57眼手术治疗的NVG患者进行回顾性分析和随访,根据手术方式分Ahmed青光眼阀( AGV)植入术组( A组,24例31眼)和半导体二极管激光经巩膜睫状体光凝术( TSCPC)组( B组,22例26眼),比较手术前后眼压、视力变化及术后并发症情况。<br> 结果：两组术后眼压均较术前显著降低(P<0.05),但组间无统计学差异(P>0.05)；两组术后视力变化比较无统计学差异(P>0.05)；A组术后并发症明显低于B组,其中眼球疼痛、前房出血发生率比较有统计学差异(P<0.05)。<br> 结论：AGV 植入术与 TSCPC 治疗 NVG 均有效,但 AGV植入术是滤过性手术,而TSCPC是睫状体破坏性手术,后者术后并发症更高。
目的：對比觀察兩種手術方法治療新生血管性青光眼( NVG)的療效。<br> 方法：對46例57眼手術治療的NVG患者進行迴顧性分析和隨訪,根據手術方式分Ahmed青光眼閥( AGV)植入術組( A組,24例31眼)和半導體二極管激光經鞏膜睫狀體光凝術( TSCPC)組( B組,22例26眼),比較手術前後眼壓、視力變化及術後併髮癥情況。<br> 結果：兩組術後眼壓均較術前顯著降低(P<0.05),但組間無統計學差異(P>0.05)；兩組術後視力變化比較無統計學差異(P>0.05)；A組術後併髮癥明顯低于B組,其中眼毬疼痛、前房齣血髮生率比較有統計學差異(P<0.05)。<br> 結論：AGV 植入術與 TSCPC 治療 NVG 均有效,但 AGV植入術是濾過性手術,而TSCPC是睫狀體破壞性手術,後者術後併髮癥更高。
목적：대비관찰량충수술방법치료신생혈관성청광안( NVG)적료효。<br> 방법：대46례57안수술치료적NVG환자진행회고성분석화수방,근거수술방식분Ahmed청광안벌( AGV)식입술조( A조,24례31안)화반도체이겁관격광경공막첩상체광응술( TSCPC)조( B조,22례26안),비교수술전후안압、시력변화급술후병발증정황。<br> 결과：량조술후안압균교술전현저강저(P<0.05),단조간무통계학차이(P>0.05)；량조술후시력변화비교무통계학차이(P>0.05)；A조술후병발증명현저우B조,기중안구동통、전방출혈발생솔비교유통계학차이(P<0.05)。<br> 결론：AGV 식입술여 TSCPC 치료 NVG 균유효,단 AGV식입술시려과성수술,이TSCPC시첩상체파배성수술,후자술후병발증경고。
AIM:To compare the effect of two surgical methods on neovascular glaucoma ( NVG) . <br> METHODS:The clinical date of 46 cases (57 eyes) with NVG underwent surgical treatment were retrospectively analyzed and followed-up. Patients were divided into Ahmed glaucoma valve ( AGV ) implantation group (group A, 24 cases, 31 eyes) and semiconductor diode laser transscleral ciliary body photocoagulation ( TSCPC) group ( group B, 22cases, 26 eyes ) according to the surgical approach. The intraocular pressure, visual acuity and postoperative complications were compared before and after operation. <br> RESULTS: The intraocular pressure postoperative in two groups were significantly lower than those preoperative (P < 0. 05), but there was no significant difference between the two groups ( P > 0. 05 ). The changes of visual acuity postoperative showed no statistical difference between the two groups (P>0. 05). The postoperative complications of group A was significantly lower than that in group B, in which the incidence of eye pain, anterior chamber bleeding were significant differences between two groups(P <0. 05). <br> CONCLUSION:AGV implantation treatment and TSCPC for NVG are both valid, but AGV implantation is filtration surgery, and TSCPC isciliary body destructive surgery, and the latter has higher rate of postoperative complications.
